Candel Therapeutics, Inc. (CADL) KPIs and segments
CADLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.40−0.41 (-7.06%)
Close on Nov 17, 2026Market cap $413.20MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Candel Therapeutics's business
Coming soon
This tab will track the numbers specific to Candel Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?